Edinburgh, 1 September, 2025: Foresight Group, a major player in private equity, recently made a significant £3.0 million investment in MyWay Digital Health Ltd (MWDH), a company focused on improving care for those with chronic diseases, especially diabetes.
Founded in 2017 from the University of Dundee, MWDH employs 30 people across Dundee, Edinburgh, and London. Their goal is simple: to enhance the lives of individuals managing long-term health conditions using innovative, cost-effective technology. Their products target diabetes, cardiovascular health, hypertension, and weight management.
Their flagship product, MyWay Diabetes, is a clinically validated tool that helps patients manage their condition more effectively. It connects seamlessly with NHS systems, offering personalized education and practical insights to both patients and healthcare providers. The platform has seen widespread use in multiple NHS regions and beyond, yielding improved patient engagement and health outcomes.
Thanks to Foresight’s funding, MWDH plans to fast-track the development of new AI-driven tools, including predictive analytics that can tailor care to individual needs. This move aligns with a growing global trend, as digital health solutions become increasingly essential in managing chronic conditions.
To guide this expansion, Dr. Umang Patel will join as Non-Executive Chair. Dr. Patel brings a wealth of experience from the healthcare and tech sectors, currently serving as Chief Clinical Information Officer at Microsoft for the EMEA region. His expertise will be pivotal as MWDH aims to reach new markets.
Debbie Wake, CEO and Co-Founder of MWDH, said: “Securing this investment from Foresight is a big step forward for us. Their support will help us grow, broaden our offerings, and reach more patients globally.”
Daniel Halliday, Managing Director at Foresight, noted: “Digital tools and AI are crucial in easing the pressures on healthcare. MWDH’s technology is not only top-notch but also proven to enhance health outcomes and reduce costs. We’re thrilled to back this team in their growth journey.”
In recent studies, health tech solutions have been shown to significantly improve chronic disease management. According to a report from the Digital Health Alliance, companies using digital tools have witnessed a 30% increase in patient adherence to treatment regimens. This points to a bright future for MWDH as they tap into the growing demand for scalable digital health solutions.
Foresight specializes in investing in promising companies, providing both equity and flexible debt to support founders and their teams. Their investment philosophy aims not just for economic returns, but also for a positive impact on communities.
ENDS
For more information, please contact:
Chris Barry, Influential: Barry@thisisinfluential.com / +44 (0)7733 103 693
Foresight Group: marketing@foresightgroup.eu
